Workflow
BPSemi(688368)
icon
Search documents
晶丰明源:8月26日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-26 11:16
Group 1 - The core point of the article is that Jingfeng Mingyuan (SH 688368) announced the convening of its 30th board meeting on August 26, 2025, to discuss the appointment of the board secretary and other documents [1] - For the fiscal year 2024, Jingfeng Mingyuan's revenue composition is 99.94% from integrated circuits and 0.06% from other businesses [1] - As of the report date, Jingfeng Mingyuan has a market capitalization of 9.1 billion yuan [1] Group 2 - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]
晶丰明源: 上海晶丰明源半导体股份有限公司第三届董事会第三十次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 11:09
Group 1 - The board of directors of Shanghai Jingfeng Mingyuan Semiconductor Co., Ltd. held its 30th meeting on August 26, 2025, with all 7 directors participating in the voting, confirming the legality and validity of the meeting procedures [1] - The board approved the adjustment of the grant price for the 2024 restricted stock incentive plan from RMB 28.28 per share to RMB 27.78 per share, with 6 votes in favor [2][3] - The board also approved the granting of reserved restricted stocks to 53 incentive objects at the adjusted price of RMB 27.78 per share, with the grant date set for August 26, 2025 [3] Group 2 - The board appointed Mr. Yang Biao as the secretary of the board, with a term lasting until the end of the current board's tenure, receiving unanimous approval from all 7 directors [3]
晶丰明源: 上海晶丰明源半导体股份有限公司第三届监事会第二十七次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 11:09
证券代码:688368 证券简称:晶丰明源 公告编号:2025-063 上海晶丰明源半导体股份有限公司 第三届监事会第二十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 具 体 内 容 详 见 公 司 于 2025 年 8 月 27 日 在 上 海 证 券 交 易 所 网 站 (www.sse.com.cn)上披露的《上海晶丰明源半导体股份有限公司关于调整 2024 年限制性股票激励计划授予价格的公告》。 (二)审议通过《关于向 2024 年限制性股票激励计划激励对象授予预留部 分限制性股票的议案》 一、监事会会议召开情况 上海晶丰明源半导体股份有限公司(以下简称"公司")第三届监事会第二 十七次会议于 2025 年 8 月 22 日以电子邮件、专人送达等方式通知了全体监事, 会议于 2025 年 8 月 26 日以现场会议方式召开。 会议由监事会主席李宁先生主持,会议应参加表决监事 3 人,实际参加表决 监事 3 人。本次监事会会议的召集和召开程序符合有关法律、行政法规、部门规 章、规范性文件和《上海晶 ...
晶丰明源: 上海晶丰明源半导体股份有限公司关于聘任董事会秘书的公告
Zheng Quan Zhi Xing· 2025-08-26 11:08
Core Points - The company has appointed Mr. Yang Biao as the new Secretary of the Board of Directors, effective immediately upon approval by the board [1] - Mr. Yang has the necessary qualifications and experience to fulfill the role, having completed the required training and not being subject to any disqualifications under relevant laws [1][3] - The previous acting Secretary of the Board, Mr. Hu Liqiang, will no longer serve in that capacity [1] Summary of Related Sections - **Appointment Details**: The board of directors approved the appointment of Mr. Yang Biao as the Secretary of the Board, with his term lasting until the end of the third board's term [1] - **Qualifications**: Mr. Yang holds a bachelor's degree and has extensive experience in the semiconductor industry, having worked in various roles within the company since 2012 [3] - **Ownership and Relationships**: Mr. Yang directly holds 36,000 shares of the company and has no related party relationships with major shareholders or other board members [3]
【机构调研记录】国泰基金调研兆易创新、特宝生物等10只个股(附名单)
Sou Hu Cai Jing· 2025-08-26 00:06
Group 1: Zhaoyi Innovation - Zhaoyi Innovation reported good growth across all business lines in Q2 2024, with NOR Flash growing in the high single digits, niche DRAM growing over 50%, and MCU close to 20% [1] - The company expects significant revenue growth in niche DRAM in the second half of the year, with contract prices continuing to rise [1] - The demand for NOR Flash is increasing due to a rise in electronic product code volume, while supply remains tight due to wafer manufacturing capacity constraints [1] Group 2: Teabo Bio - Teabo Bio is focusing on functional cure for hepatitis B through a combination of different mechanism drugs with interferons and nucleoside analogs [2] - The company aims to provide comprehensive management of hepatitis B through a wide-reaching clinical cure network [2] - Collaboration with Ligos is underway to explore reinfection control after clearing infected cells [2] Group 3: Ruijie Networks - Ruijie Networks saw significant revenue growth in data center products, primarily driven by internet clients, with over 90% of revenue coming from this sector [3] - The company anticipates continued strong demand for cloud computing infrastructure in the second half of the year [3] - The gross margin for data center products is relatively low (15%-20%), while margins in enterprise and SMB markets have improved [3] Group 4: Trina Solar - Trina Solar is focusing on maintaining fair competition in the photovoltaic industry and promoting healthy development [4] - The company aims for over 8GWh in the storage segment for the year, with an increasing proportion of overseas orders [4] - The demand in the U.S. market is accelerating, leading to increased component prices and optimized supply chains [4] Group 5: Liangxin Co. - Liangxin Co. has segmented its data center business into three main areas: internet enterprises, operators, and individual projects, with a focus on HVDC and UPS [5] - The company is expected to continue its efforts in digital energy and infrastructure despite a potential slowdown in the renewable energy sector [5] - The gross margin for overseas business has slightly decreased compared to the previous year [5] Group 6: Baillie Tianheng - Baillie Tianheng is advancing three key overseas clinical trials for treating triple-negative breast cancer, EGFR-mutant non-small cell lung cancer, and urothelial carcinoma [6] - The company has submitted its first nuclear medicine candidate drug for domestic IND application [6] - R&D expenses reached 1.038 billion yuan by mid-year, with expectations for future clinical research costs to increase [6] Group 7: Jingfeng Mingyuan - Jingfeng Mingyuan has achieved an increase in overall gross margin through cost reduction and efficiency improvements [7] - The company is expanding its market presence in smart LED lighting products despite a decline in sales and prices in traditional LED lighting [7] - The high-performance computing power supply chip business has seen rapid growth, with products entering large-scale sales [7] Group 8: Chipone - Chipone is providing various customized hardware and software solutions in the AI field, serving multiple international giants [8] - The company has a high percentage of R&D personnel, with 89.31% of staff engaged in research and development [8] - Chipone is advancing Chiplet technology and has achieved success in designing high-performance automotive chips [8] Group 9: Xiasha Precision - Xiasha Precision reported a 30.77% increase in revenue for the first half of 2025, but a 41.87% decline in net profit due to price competition and rising costs [9] - The company plans to expand its product line in joint modules and increase R&D investment [9] - A new factory in Vietnam is under trial production, with plans to expand into overseas markets [9] Group 10: Lepu Medical - Lepu Medical's subsidiary focuses on elderly care services and has developed a facial filler product that has received regulatory approval [10] - The company is advancing AI products that monitor vital signs through various hardware applications [10] - Lepu Medical has a significant asset management scale, ranking 14th among 210 in public fund management [10]
晶丰明源股价微涨0.01% 半年度净利润同比上升151.67%
Jin Rong Jie· 2025-08-25 18:44
Core Viewpoint - The stock price of Jingfeng Mingyuan reached 102.59 yuan as of August 25, 2025, showing a slight increase of 0.01 yuan or 0.01% from the previous trading day [1] Group 1: Company Performance - Jingfeng Mingyuan's main business involves the research, design, and sales of analog and mixed-signal integrated circuits, with applications in LED lighting, home appliances, and power management [1] - For the first half of 2025, the company reported a sales revenue of 731 million yuan and a net profit attributable to shareholders of 15.76 million yuan, marking an increase of 46.27 million yuan or 151.67% year-on-year [1] Group 2: Market Activity - On August 25, 2025, the company announced that it had received institutional research visits from several firms, including CITIC Securities, Bank of Communications Fund, and Guotai Fund, between August 18 and 22, focusing on the company's semi-annual performance [1] - Over the past year, the company has hosted 641 research visits from 403 institutions [1] Group 3: Capital Flow - On August 25, 2025, the net inflow of main funds was 9.35 million yuan, accounting for 0.1% of the circulating market value [1] - Over the past five days, the cumulative net outflow of main funds was 37.11 million yuan, representing 0.41% of the circulating market value [1]
近33亿!晶丰明源出手!
是说芯语· 2025-08-25 02:41
Core Viewpoint - The article discusses the acquisition of Easy Charge Technology by Shanghai Jingfeng Mingyuan Semiconductor Co., Ltd. for 3.283 billion RMB (approximately 457 million USD) to enhance its product portfolio and competitiveness in the semiconductor industry [3][8]. Group 1: Company Overview - Shanghai Jingfeng Mingyuan, established in 2008, specializes in power management and control driver chips, with applications in various sectors including home appliances, mobile phones, and automotive [5][7]. - Easy Charge Technology, founded in 2016, is a leading provider of power management solutions, focusing on high-performance analog chips and mixed-signal integrated circuits, including wireless charging chips [5][10]. Group 2: Acquisition Details - The acquisition aims to strengthen Jingfeng Mingyuan's position in the "hard technology" sector and enhance its international competitiveness by integrating Easy Charge's resources [8][19]. - The transaction is characterized by a high premium, with an estimated valuation of Easy Charge at 3.29 billion RMB, reflecting a premium rate of 260.08% [16][17]. Group 3: Financial Performance - Easy Charge has reported losses in recent years, with projected losses of 502 million RMB and 512 million RMB for 2023 and 2024, respectively, totaling over 1 billion RMB in losses [14][16]. - Jingfeng Mingyuan has also faced profitability challenges, with net losses reported in the past three years, although it achieved a revenue of 1.504 billion RMB in 2024, a year-on-year increase of 15.38% [18]. Group 4: Strategic Implications - The acquisition is expected to enhance product offerings in wireless charging and automotive electronics, leveraging Easy Charge's established customer base, including major brands like Samsung and BYD [19][20]. - Performance commitments have been set for Easy Charge's business segments from 2025 to 2027, ensuring minimum net profits and revenues, which may provide a framework for long-term value realization [20][21].
社保基金现身29只科创板股前十大流通股东榜
Core Insights - The Social Security Fund has disclosed its stock holdings as of the end of Q2, appearing in the top ten shareholders of 29 stocks on the Sci-Tech Innovation Board, with a total holding of 94.71 million shares valued at 4.23 billion yuan [1][2] Group 1: Stock Holdings - The Social Security Fund has newly entered 6 stocks and increased holdings in 8 stocks, while reducing holdings in 7 stocks, with 8 stocks remaining unchanged [1] - The stocks with the highest holdings by the Social Security Fund include Daotong Technology with 9.27 million shares, followed by Times Electric and ST Nuotai with 6.31 million and 5.72 million shares respectively [2][3] - The highest holding ratio is for Haitai Xinguang at 4.20%, followed by Aopumai at 4.00% [2] Group 2: Financial Performance - Among the stocks held by the Social Security Fund, 25 companies reported year-on-year net profit growth in the first half of the year, with Rongzhi Rixin showing the highest growth rate of 2063.42% [2] - Other notable profit growth includes Xinxing Microelectronics and Jingfeng Mingyuan, with increases of 261.78% and 151.67% respectively [2] Group 3: Market Performance - Stocks held by the Social Security Fund on the Sci-Tech Innovation Board have averaged a 22.67% increase since July [3] - The best-performing stock is Dingtong Technology, with a cumulative increase of 69.16%, followed by Yuandong Biology and Kaiyin Technology with increases of 54.02% and 39.07% respectively [3]
晶丰明源(688368) - 上海晶丰明源半导体股份有限公司发行股份及支付现金购买资产并募集配套资金报告书(草案)摘要(修订稿)
2025-08-19 16:02
购买资产并募集配套资金报告书(草案) 摘要(修订稿) | 项目 | 交易对方 | | --- | --- | | 发行股份及支付 | 海南玮峻思投资合伙企业(有限合伙)等 名易冲科 50 | | 现金购买资产 | 技股东 | | 募集配套资金 | 不超过 35 名符合中国证监会规定的特定投资者 | 独立财务顾问 签署日期:二〇二五年八月 声 明 股票代码:688368 股票简称:晶丰明源 上市地点:上海证券交易所 上海晶丰明源半导体股份有限公司 发行股份及支付现金 本部分所述词语或简称与报告书摘要"释义"所述词语或简称具有相同含义。 一、上市公司声明 本公司及本公司全体董事、监事及高级管理人员保证上市公司及时、公平地披露 信息,保证报告书及其摘要内容的真实、准确、完整,不存在虚假记载、误导性陈述 或者重大遗漏,保证报告书所引用的相关数据的真实性和合理性,并对所提供信息的 真实性、准确性、完整性负相应的法律责任。 如本次交易所披露或提供的信息涉嫌虚假记载、误导性陈述或者重大遗漏,被司 法机关立案侦查或者被中国证监会立案调查的,在形成调查结论以前,不转让在该上 市公司拥有权益的股份,并于收到立案稽查通知的两个交易 ...
晶丰明源(688368) - 上海晶丰明源半导体股份有限公司发行股份及支付现金购买资产并募集配套资金报告书(草案)(修订稿)
2025-08-19 16:02
股票代码:688368 股票简称:晶丰明源 上市地点:上海证券交易所 发行股份及支付现金 购买资产并募集配套资金报告书(草案) (修订稿) | 发行股份及支付 | 海南玮峻思投资合伙企业(有限合伙)等 50 名易冲科 | | --- | --- | | 现金购买资产 | 技股东 | | 募集配套资金 | 不超过 35 名符合中国证监会规定的特定投资者 | 独立财务顾问 签署日期:二〇二五年八月 上海晶丰明源半导体股份有限公司 项目 交易对方 上海晶丰明源半导体股份有限公司发行股份及支付现金购买资产并募集配套资金报告书(草案)(修订稿) 声 明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 中国证监会、上交所对本次交易所作的任何决定或意见均不代表其对本公司股票 的价值或投资者收益的实质性判断或保证。 根据《证券法》等相关法律、法规的规定,本次交易完成后,本公司经营与收益 的变化,由本公司自行负责,由此变化引致的投资风险,由投资者自行负责。投资者 在评价公司本次交易时,除本报告书内容以及与本报告书同时披露的相关文件外,还 应认真地考虑本报告书披露的各项风险因素。投资者若对本报告书存在任何疑问 ...